Influence of genetic biomarkers on cardiac diseases in childhood cancer survivors: a systematic review
Authors:
Open Access
- 24 May 2025
- journal article
- review article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 25 (3) , 1-12
Abstract
Childhood cancer survivors (CCS) often suffer from cardiac disease (CD) after treatment that included anthracycline and radiotherapy involving the heart. However, the variability in CD occurrence cannot be explained solely by these treatments, suggesting the existence of genetic predisposition. We conducted a systematic review searching on Medline-PubMed and Scopus, to identify studies reporting associations between genetic factors and CD in CCS. We included studies published up to 11 April 2023, with no lower limit, and assessed the quality of genetic associations by the Q-genie tool. As a result, 20 studies were included (15 case-control and five cohorts), revealing several genes and variants associated with cardiomyopathy, among which, SLC28A3-rs7853758, RARG-rs2229774, P2RX7-rs208294 and P2RX7-rs3751143 variants gave the most consistent findings. This review highlights the necessity to establish a set of clinically useful genes and variants to identify patients most at risk of developing cardiomyopathy, and to implement monitoring and prevention strategies.Keywords
Funding Information
- Fondation ARC pour la Recherche sur le Cancer (ARCDOC42023010005942)
- Doctoral grant from the Paris Sud-Paris Saclay University
This publication has 61 references indexed in Scilit:
- Long-term Cause-Specific Mortality Among Survivors of Childhood CancerJAMA, 2010
- Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohortBMJ, 2009
- Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline‐related congestive heart failure after childhood cancerCancer, 2008
- Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood CancerJAMA, 2007
- Inhibitory effects of different antioxidants on hyaluronan depolymerizationCarbohydrate Research, 2007
- The ATP-Binding Cassette Transporters and Their Implication in Drug Disposition: A Special Look at the HeartPharmacological Reviews, 2006
- Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2005
- Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell deathAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damageThe FASEB Journal, 2004
- Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapyRadiotherapy and Oncology, 1996